SCHEMBL31159824

SCHEMBL31159824

COC(=O)c1cc(NC(C)C)c(N)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.42
▸ POLB P06746 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 3/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ CNR2 P34972 1/20 0.40
▸ MELK Q14680 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27255559 0.83 KDM4E (0.45) KDM4EPOLBMAPTLMNACNR2
SCHEMBL10683847 0.82 KDM4E (0.53) KDM4EPOLBMAPTLMNACNR2
SCHEMBL31160023 0.77 SMN1; SMN2 (0.50) KDM4EMAPTLMNAALDH1A1KMT2A
SCHEMBL30418756 0.77 KDM4E (0.53) KDM4EPOLBMAPTLMNACNR2
SCHEMBL18031417 0.77 KDM4E (0.53) KDM4EPOLBMAPTLMNACNR2
SCHEMBL23905892 0.76 CNR2 (0.49) KDM4EPOLBMAPTLMNACNR2
SCHEMBL26579774 0.76 KDM4E (0.58) KDM4EPOLBMAPTLMNACNR2
SCHEMBL1457837 0.76 CA12 (0.46) KDM4EPOLBMAPTLMNACNR2
SCHEMBL25351231 0.75 HDAC1 (0.55) KDM4EMAPTLMNAALDH1A1KMT2A
SCHEMBL31160000 0.74 MAPT (0.40) KDM4EMAPTLMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688144-A1 COMPOUNDS AS GLP-1R AGONISTS Terns Pharmaceuticals, Inc. (US) 2026-02-11 — — EP disclosed
WO-2024206878-A1 COMPOUNDS AS GLP-1R AGONISTS TERNS PHARMACEUTICALS, INC. (US) 2024-10-03 — — WO disclosed
Send feedback